Ewa Wajs
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
-
- Diabetes Treatment and Management
- Diabetes Management and Research
Papers in
-
- Gastroesophageal reflux and treatments 5
- Gastrointestinal motility and disorders 5
- Co-authors
- Keith UsiskinGary MeiningerJ.‐F. YaleDennis K. YueElias David‐NetoBertrand CariouLiwen XiGeorge L. Bakris
- Journals
- Journal of Pineal Research (3 papers)The International Journal of Neuropsychopharmacology (3 papers)Clinical Therapeutics (3 papers)European Neuropsychopharmacology (3 papers)Neurogastroenterology & Motility (3 papers)
- Partner nations
- BelgiumUnited StatesPoland
In The Last Decade
Ewa Wajs
43 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Biological Psychiatry 132
- Endocrinology, Diabetes and Metabolism 813
- Nephrology 151
- Gastroenterology 113
- Pharmacology 325
Countries citing papers authored by Ewa Wajs
This map shows the geographic impact of Ewa Wajs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Wajs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Wajs more than expected).
Fields of papers citing papers by Ewa Wajs
This network shows the impact of papers produced by Ewa Wajs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Wajs. The network helps show where Ewa Wajs may publish in the future.
Co-authors
The 25 scholars most cited alongside Ewa Wajs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 27 | |
| 3 | 2020 | 28 | |
| 4 | Effect of esketamine nasal spray on cognition in patients with treatment-resistant depression: results from five phase-3 studies | 2019 | 1 |
| 5 | 2017 | 22 | |
| 6 | 2015 | 12 | |
| 7 | 2014 | 42 | |
| 8 | Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease Hit paper breakdown → | 2013 | 418 |
| 9 | 2009 | 38 | |
| 10 | 2009 | 2 | |
| 11 | 2009 | 60 | |
| 12 | 2008 | 33 | |
| 13 | 2006 | 5 | |
| 14 | 2006 | 31 | |
| 15 | 1995 | 23 | |
| 16 | 1991 | 32 | |
| 17 | 1991 | 1 | |
| 18 | 1991 | 1 | |
| 19 | 1990 | 3 | |
| 20 | 1990 | 7 |
About Ewa Wajs
Ewa Wajs is a scholar working on Biological Psychiatry, Gastroenterology, Endocrinology, Diabetes and Metabolism, Endocrine and Autonomic Systems and Pharmacology, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (12 papers), Treatment of Major Depression (11 papers), Neuroendocrine Tumor Research Advances (7 papers), Pancreatic function and diabetes (7 papers), Helicobacter pylori-related gastroenterology studies (6 papers), Gastroesophageal reflux and treatments (5 papers), Gastrointestinal motility and disorders (5 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). The work is most often cited by research in Biological Psychiatry (132 citations), Endocrinology, Diabetes and Metabolism (813 citations), Nephrology (151 citations), Gastroenterology (113 citations) and Pharmacology (325 citations). Ewa Wajs has collaborated with scholars based in Belgium, United States and Poland. Frequent co-authors include Keith Usiskin, Gary Meininger, J.‐F. Yale, Dennis K. Yue, Elias David‐Neto, Bertrand Cariou, Liwen Xi, George L. Bakris, Damayanthi Devineni and Jaskaran Singh. Their work appears in journals such as Journal of Pineal Research, The International Journal of Neuropsychopharmacology, Clinical Therapeutics, European Neuropsychopharmacology and Neurogastroenterology & Motility.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.